About the Journal of Clinical Oncology

Kantar Media May 2022 Med/Surg Readership Study (Onc)

Journal of Clinical Oncology (JCO) serves its readers as the most credible and authoritative resource for disseminating significant clinical oncology research. In print and online, JCO strives to publish the highest quality articles dedicated to clinical research.

Original Reports are the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other articles that relate to the care of patients with cancer.

Acceptance of articles to online publication time: 41 days

Acceptance of articles to print publication time: 104 days

Manuscript acceptance rate: 20% (12% for Original Reports)

History, Mission, and Vision

• Founded 1964
• Approximately 45,000 members in more than 150 countries
• Largest clinical oncology scientific meeting in the world, with approximately 40,000 attendees annually
• Mission: Conquering cancer through research, education, and promotion of the highest quality, equitable patient care.
• Vision: A world where cancer is prevented or cured, and every survivor is healthy

Printed on .
All information in this media kit is subject to change. View the most current version of this media kit online at hbside.com.